Targeting mitochondrial DNA repair for novel anti-cancer therapies (Q84259): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed label, description and/or aliases in 1 language: translated_label)
(‎Changed label, description and/or aliases in 2 languages: Changing unique label-description pair)
description / endescription / en
Project in Poland financed by DG Regio
Project Q84259 in Poland
description / pldescription / pl
Projekt w Polsce finansowany przez DG Regio
Projekt Q84259 w Polsce

Revision as of 05:23, 29 October 2020

Project Q84259 in Poland
Language Label Description Also known as
English
Targeting mitochondrial DNA repair for novel anti-cancer therapies
Project Q84259 in Poland

    Statements

    0 references
    3,200,000.0 zloty
    0 references
    768,000.0 Euro
    13 January 2020
    0 references
    3,200,000.0 zloty
    0 references
    768,000.0 Euro
    13 January 2020
    0 references
    100.0 percent
    0 references
    1 March 2018
    0 references
    28 February 2023
    0 references
    UNIWERSYTET GDAŃSKI
    0 references
    Mitochondrial DNA, partially associated with mitochondrial inner membrane, is at the heart of ROS production thus, relative to nuDNA, mtDNA contains high levels of oxidative damage. Many of these damages are mutagenic and cause disease. Located on the inner membrane, base excision repair pathway is a major defense mechanism against oxidative damage. EXOG, a membrane-bound 5'-exo/endonuclease, is crucial for mtDNA repair. Depletion of EXOG causes accumulation of DNA damage in the mitochondria, but not in the nucleus, increases oxidative stress and mitochondrial dysfunction and leads to cell death. We propose that N-terminal transmembrane domain of EXOG anchors BER repairosome to mitochondrial inner membrane and modulates crucial 5'exonuclease activity of the enzyme. Because preservation of mtDNA integrity in cancer cells is a key for cancer progression, we aim to develop inhibitors to specifically halt function of EXOG and increase sensitivity to traditional chemotherapeutics. (Polish)
    0 references
    Mitochondrial DNA, partially associated with mitochondrial inner membrane, is at the heart of ROS production thus, relative to boring, mtDNA contains high levels of oxidative damage. Many of these damages are Mutagenic and cause disease. Located on the inner membrane, base excision repair pathway is a major defense mechanism against oxidative damage. EXOG, a membrane-bound 5'-exo/endonuclease, is crucial for mtDNA repair. Depletion of EXOG causes accumulation of DNA damage in the mitochondria, but not in the nucleus, increases oxidative stress and mitochondrial dysfunction and leads to cell death. We propose that N-terminal transmembrane domain of EXOG anchors BER repairosome to mitochondrial inner membrane and modulates crucial 5'exonuclease activity of the enzyme. Because preservation of mtDNA integrity in cancer cells is a key for cancer progression, we aim to develop inhibitors to specifically halt function of EXOG and increase sensitivity to traditional chemotherapeutics. (English)
    14 October 2020
    0 references

    Identifiers

    POIR.04.04.00-00-3E44/17
    0 references